Pipeline

Indi Molecular is pursuing a hybrid strategy that emphasizes strategic partnerships in biological tools and in vitro diagnostics. We are also pursuing partnerships to bring the benefits of PCC technology to in vivo PET imaging and therapeutics.

PCC’s unsurpassed chemical stability, high chemical selectivity, speed of preparation, low production cost and exact chemical composition confer distinct advantages in each of these fields that molecular antibodies cannot match. Applications range from displacing antibody-dominated techniques in both biological tools and in vitro diagnostics settings, to groundbreaking potential advances in molecular in vivo imaging and targeted therapeutics.